BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 18059157)

  • 1. Radiosensitization of prostate cancer by priming the wild-type p53-dependent cellular senescence pathway.
    Lehmann BD; McCubrey JA; Terrian DM
    Cancer Biol Ther; 2007 Aug; 6(8):1165-70. PubMed ID: 18059157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dominant role for p53-dependent cellular senescence in radiosensitization of human prostate cancer cells.
    Lehmann BD; McCubrey JA; Jefferson HS; Paine MS; Chappell WH; Terrian DM
    Cell Cycle; 2007 Mar; 6(5):595-605. PubMed ID: 17351335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depletion of securin induces senescence after irradiation and enhances radiosensitivity in human cancer cells regardless of functional p53 expression.
    Chen WS; Yu YC; Lee YJ; Chen JH; Hsu HY; Chiu SJ
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):566-74. PubMed ID: 20457353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDM2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Ablation and Radiotherapy in a p53-Dependent Manner.
    Feng FY; Zhang Y; Kothari V; Evans JR; Jackson WC; Chen W; Johnson SB; Luczak C; Wang S; Hamstra DA
    Neoplasia; 2016 Apr; 18(4):213-22. PubMed ID: 27108384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53-Dependent accelerated senescence induced by ionizing radiation in breast tumour cells.
    Jones KR; Elmore LW; Jackson-Cook C; Demasters G; Povirk LF; Holt SE; Gewirtz DA
    Int J Radiat Biol; 2005 Jun; 81(6):445-58. PubMed ID: 16308915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of P53-Senescence Induction in Suppression of LNCaP Prostate Cancer Growth by Cardiotonic Compound Bufalin.
    Zhang Y; Dong Y; Melkus MW; Yin S; Tang SN; Jiang P; Pramanik K; Wu W; Kim S; Ye M; Hu H; Lu J; Jiang C
    Mol Cancer Ther; 2018 Nov; 17(11):2341-2352. PubMed ID: 30166403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ser46 phosphorylation regulates p53-dependent apoptosis and replicative senescence.
    Feng L; Hollstein M; Xu Y
    Cell Cycle; 2006 Dec; 5(23):2812-9. PubMed ID: 17172844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epibrassinolide-induced apoptosis regardless of p53 expression via activating polyamine catabolic machinery, a common target for androgen sensitive and insensitive prostate cancer cells.
    Obakan P; Arisan ED; Coker-Gurkan A; Palavan-Unsal N
    Prostate; 2014 Dec; 74(16):1622-33. PubMed ID: 25214240
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Parisotto M; Grelet E; El Bizri R; Dai Y; Terzic J; Eckert D; Gargowitsch L; Bornert JM; Metzger D
    J Exp Med; 2018 Jun; 215(6):1749-1763. PubMed ID: 29743291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation-induced apoptosis of human prostate cancer cells is independent of mutant p53 overexpression.
    Kyprianou N; Rock S
    Anticancer Res; 1998; 18(2A):897-905. PubMed ID: 9615738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-derived growth factor (PDGF)-signaling mediates radiation-induced apoptosis in human prostate cancer cells with loss of p53 function.
    Kim HE; Han SJ; Kasza T; Han R; Choi HS; Palmer KC; Kim HR
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):731-6. PubMed ID: 9336156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor.
    Coppé JP; Patil CK; Rodier F; Sun Y; Muñoz DP; Goldstein J; Nelson PS; Desprez PY; Campisi J
    PLoS Biol; 2008 Dec; 6(12):2853-68. PubMed ID: 19053174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional p53 increases prostate cancer cell survival after exposure to fractionated doses of ionizing radiation.
    Scott SL; Earle JD; Gumerlock PH
    Cancer Res; 2003 Nov; 63(21):7190-6. PubMed ID: 14612513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutlin-3 radiosensitizes hypoxic prostate cancer cells independent of p53.
    Supiot S; Hill RP; Bristow RG
    Mol Cancer Ther; 2008 Apr; 7(4):993-9. PubMed ID: 18413812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of p53 by Nutlin-3a, an antagonist of MDM2, induces apoptosis and cellular senescence in adult T-cell leukemia cells.
    Hasegawa H; Yamada Y; Iha H; Tsukasaki K; Nagai K; Atogami S; Sugahara K; Tsuruda K; Ishizaki A; Kamihira S
    Leukemia; 2009 Nov; 23(11):2090-101. PubMed ID: 19710698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct roles for p107 and p130 in Rb-independent cellular senescence.
    Lehmann BD; Brooks AM; Paine MS; Chappell WH; McCubrey JA; Terrian DM
    Cell Cycle; 2008 May; 7(9):1262-8. PubMed ID: 18418057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Senescence-associated exosome release from human prostate cancer cells.
    Lehmann BD; Paine MS; Brooks AM; McCubrey JA; Renegar RH; Wang R; Terrian DM
    Cancer Res; 2008 Oct; 68(19):7864-71. PubMed ID: 18829542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a DNA Damage-Induced Alternative Splicing Pathway That Regulates p53 and Cellular Senescence Markers.
    Chen J; Crutchley J; Zhang D; Owzar K; Kastan MB
    Cancer Discov; 2017 Jul; 7(7):766-781. PubMed ID: 28288992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular mechanism of cell death by radiation].
    Watanabe M; Suzuki K; Kodama S
    Nihon Igaku Hoshasen Gakkai Zasshi; 2002 Sep; 62(10):540-4. PubMed ID: 12391682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b, and mir-34c expression, and induce senescence.
    Kumamoto K; Spillare EA; Fujita K; Horikawa I; Yamashita T; Appella E; Nagashima M; Takenoshita S; Yokota J; Harris CC
    Cancer Res; 2008 May; 68(9):3193-203. PubMed ID: 18451145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.